Pfizer Inc SEC filings PFE
Pfizer Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 26, 2021. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| N-PX | Filing | Aug 31, 2026 | Jun 30, 2026 |
| 11-K | Employee savings plan report | Jun 16, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 16, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 16, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 16, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| CERT | Nyse certification | May 20, 2025 | — |
| 8-A12B | Filing | May 19, 2025 | — |
| POSASR | Filing | May 13, 2025 | — |
| PX14A6G | Filing | Mar 25, 2025 | — |
| SC TO-I/A | Pfizer sc to-i/a amendment 2 final | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 22, 2024 | — |
| SC TO-I/A | Filing | Aug 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| SC TO-I | Filing | Aug 12, 2024 | — |
| SC TO-C | Sc to-c pre communication | Aug 1, 2024 | — |
| SC TO-C | Sc to-c pre communicatuns | Jul 30, 2024 | — |
| SC TO-C | Pfizer sc to-c | Jul 26, 2024 | — |
| 11-K | Employee savings plan report | Jun 11, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 11, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| PX14A6G | Filing | Apr 16, 2024 | — |
| 11-K | Employee savings plan report | Jun 20, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 20, 2023 | Dec 31, 2022 |
| POSASR | Filing | May 15, 2023 | — |
| PX14A6G | Filing | Apr 12, 2023 | — |
| PX14A6G | Filing | Apr 4, 2023 | — |
| PX14A6G | Pfizer | Mar 22, 2023 | — |
| 11-K | Employee savings plan report | Jun 9, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 9, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | Apr 14, 2022 | — |
| PX14A6G | Filing | Apr 14, 2022 | — |
| CORRESP | Letter to the SEC | Apr 12, 2022 | — |
| PX14A6G | Filing | Mar 21, 2022 | — |
| PX14A6G | Filing | Mar 21, 2022 | — |
| 25-NSE | Delisting notice | Mar 7, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2021 | — |
| 11-K | Employee savings plan report | Jun 7, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 7, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 7, 2021 | Dec 31, 2020 |
| PX14A6G | Filing | Mar 23, 2021 | — |
| PX14A6G | Filing | Mar 22, 2021 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PFE (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 78003
- Former names
- PFIZER INC (until Nov 3, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.